Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
Evofem Biosciences, Inc. (EVFM) had Return on Assets of -12.40% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$4.83M |
|
$-1.78M |
|
$0.76M |
|
$4.07M |
|
$6.08M |
|
$-1.25M |
|
$-0.53M |
|
$-1.78M |
|
$-1.78M |
|
$-1.78M |
|
$-1.78M |
|
$-1.78M |
|
$-1.78M |
|
$-1.25M |
|
$-1.12M |
|
115.69M |
|
115.69M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$8.97M |
|
$0.42M |
|
$5.41M |
|
$14.38M |
|
$73.89M |
|
-- |
|
$5.32M |
|
$79.21M |
|
$-69.62M |
|
$-69.57M |
|
$-64.83M |
|
118.66M |
|
| Cash Flow Statement Financials | |
$-2.36M |
|
$-0.06M |
|
$2.42M |
|
$0.74M |
|
$0.75M |
|
$0.01M |
|
$0.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.12 |
|
-- |
|
-- |
|
-- |
|
-0.73 |
|
84.35% |
|
-25.93% |
|
-25.93% |
|
-- |
|
-36.83% |
|
-36.99% |
|
$-2.42M |
|
-- |
|
-- |
|
-- |
|
0.34 |
|
0.40 |
|
0.98 |
|
92.03 |
|
2.56% |
|
2.56% |
|
|
Return on Assets |
-12.40% |
2.75% |
|
$-0.55 |
|
$-0.02 |
|
$-0.02 |
|